Ott MG[au] - Search Results

Year	Number of Results
1954	1
1955	1
1974	1
1975	2
1976	2
1977	3
1978	3
1979	1
1980	5
1983	4
1984	1
1985	2
1986	1
1987	2
1988	1
1989	2
1990	3
1991	3
1992	2
1993	2
1994	2
1995	1
1996	5
1997	2
1998	2
1999	1
2000	4
2002	3
2003	1
2004	2
2005	1
2006	5
2007	7
2008	1
2009	3
2010	2
2011	2
2012	1
2013	1
2014	1
2017	1
2022	0

1

Issues in diisocyanate antibody testing.

Ott MG, Jolly AT, Burkert AL, Brown WE. Ott MG, et al. Crit Rev Toxicol. 2007;37(7):567-85. doi: 10.1080/10408440701419553. Crit Rev Toxicol. 2007. PMID: 17674212 Review.

2

Diisocyanates in polyurethane plastics applications.

Klees JE, Ott MG. Klees JE, et al. Among authors: ott mg. Occup Med. 1999 Oct-Dec;14(4):759-76. Occup Med. 1999. PMID: 10495484 Review.

3

Assessment of 1,3-butadiene epidemiology studies.

Ott MG. Ott MG. Environ Health Perspect. 1990 Jun;86:135-41. doi: 10.1289/ehp.9086135. Environ Health Perspect. 1990. PMID: 2205483 Free PMC article. Review.

4

Progress and prospects: gene therapy clinical trials (part 1).

Alexander BL, Ali RR, Alton EW, Bainbridge JW, Braun S, Cheng SH, Flotte TR, Gaspar HB, Grez M, Griesenbach U, Kaplitt MG, Ott MG, Seger R, Simons M, Thrasher AJ, Thrasher AZ, Ylä-Herttuala S. Alexander BL, et al. Among authors: ott mg. Gene Ther. 2007 Oct;14(20):1439-47. doi: 10.1038/sj.gt.3303001. Gene Ther. 2007. PMID: 17909539 Review.

5

Advances in the treatment of Chronic Granulomatous Disease by gene therapy.

Ott MG, Seger R, Stein S, Siler U, Hoelzer D, Grez M. Ott MG, et al. Curr Gene Ther. 2007 Jun;7(3):155-61. doi: 10.2174/156652307780859044. Curr Gene Ther. 2007. PMID: 17584034 Review.

6

Exposure assessment as a component of observational health studies and environmental risk assessment.

Ott MG. Ott MG. Scand J Work Environ Health. 2005;31 Suppl 1:110-4; discussion 63-5. Scand J Work Environ Health. 2005. PMID: 16190157 Free article. Review.

7

Respiratory effects of toluene diisocyanate in the workplace: a discussion of exposure-response relationships.

Ott MG, Diller WF, Jolly AT. Ott MG, et al. Crit Rev Toxicol. 2003;33(1):1-59. doi: 10.1080/713611031. Crit Rev Toxicol. 2003. PMID: 12585506 Review.

8

Occupational asthma, lung function decrement, and toluene diisocyanate (TDI) exposure: a critical review of exposure-response relationships.

Ott MG. Ott MG. Appl Occup Environ Hyg. 2002 Dec;17(12):891-901. doi: 10.1080/10473220290107093. Appl Occup Environ Hyg. 2002. PMID: 12495600 Review.

9

Gene therapy for chronic granulomatous disease.

Stein S, Siler U, Ott MG, Seger R, Grez M. Stein S, et al. Among authors: ott mg. Curr Opin Mol Ther. 2006 Oct;8(5):415-22. Curr Opin Mol Ther. 2006. PMID: 17078383 Review.

10

Screening for pre-diabetes and diabetes in the workplace.

Oberlinner C, Neumann SM, Ott MG, Zober A. Oberlinner C, et al. Among authors: ott mg. Occup Med (Lond). 2008 Jan;58(1):41-5. doi: 10.1093/occmed/kqm129. Epub 2007 Nov 19. Occup Med (Lond). 2008. PMID: 18025060

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results